Results 1 to 10 of about 7,903,864 (271)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer

open access: yesSignal Transduction and Targeted Therapy, 2023
Angiogenesis, the formation of new blood vessels, is a complex and dynamic process regulated by various pro- and anti-angiogenic molecules, which plays a crucial role in tumor growth, invasion, and metastasis.
Zhenling Liu   +4 more
semanticscholar   +1 more source

Neoantigens: promising targets for cancer therapy

open access: yesSignal Transduction and Targeted Therapy, 2023
Recent advances in neoantigen research have accelerated the development and regulatory approval of tumor immunotherapies, including cancer vaccines, adoptive cell therapy and antibody-based therapies, especially for solid tumors.
N-N Xie   +5 more
semanticscholar   +1 more source

Smart nanoparticles for cancer therapy

open access: yesSignal Transduction and Targeted Therapy, 2023
Smart nanoparticles, which can respond to biological cues or be guided by them, are emerging as a promising drug delivery platform for precise cancer treatment.
Leming Sun   +8 more
semanticscholar   +1 more source

Targeting p53 pathways: mechanisms, structures and advances in therapy

open access: yesSignal Transduction and Targeted Therapy, 2023
The TP53 tumor suppressor is the most frequently altered gene in human cancers, and has been a major focus of oncology research. The p53 protein is a transcription factor that can activate the expression of multiple target genes and plays critical roles ...
Haolan Wang   +3 more
semanticscholar   +1 more source

Targeting integrin pathways: mechanisms and advances in therapy

open access: yesSignal Transduction and Targeted Therapy, 2023
Integrins are considered the main cell-adhesion transmembrane receptors that play multifaceted roles as extracellular matrix (ECM)-cytoskeletal linkers and transducers in biochemical and mechanical signals between cells and their environment in a wide ...
Xiaocong Pang   +9 more
semanticscholar   +1 more source

Endovascular therapy for ischemic stroke with perfusion-imaging selection.

open access: yesNew England Journal of Medicine, 2015
BACKGROUND Trials of endovascular therapy for ischemic stroke have produced variable results. We conducted this study to test whether more advanced imaging selection, recently developed devices, and earlier intervention improve outcomes.
B. Campbell   +35 more
semanticscholar   +1 more source

In Silico Implementation of Evolutionary Paradigm in Therapy Design: Towards Anti-Cancer Therapy as Darwinian Process [PDF]

open access: yesJournal of Theoretical Biology 485(2020) 110038, 2018
In here presented in silico study we suggest a way how to implement the evolutionary principles into anti-cancer therapy design. We hypothesize that instead of its ongoing supervised adaptation, the therapy may be constructed as a self-sustaining evolutionary process in a dynamic fitness landscape established implicitly by evolving cancer cells ...
arxiv   +1 more source

Nanomedicine in cancer therapy

open access: yesSignal Transduction and Targeted Therapy, 2023
Cancer remains a highly lethal disease in the world. Currently, either conventional cancer therapies or modern immunotherapies are non-tumor-targeted therapeutic approaches that cannot accurately distinguish malignant cells from healthy ones, giving rise
Dahua Fan   +5 more
semanticscholar   +1 more source

Engineered exosomes from different sources for cancer-targeted therapy

open access: yesSignal Transduction and Targeted Therapy, 2023
Exosome is a subgroup of extracellular vesicles, which has been serving as an efficient therapeutic tool for various diseases. Engineered exosomes are the sort of exosomes modified with surface decoration and internal therapeutic molecules.
Menghui Zhang   +7 more
semanticscholar   +1 more source

Incubation periods under various anti-retroviral therapies in homogeneous mixing and age-structured dynamical models: A theoretical approach [PDF]

open access: yesRocky Mountain Journal of Mathematics, (2015), 45, 3: 973-1031, 2006
With the launch of second line anti-retroviral therapy for HIV infected individuals, there has been an increased expectation on surviving period of people with HIV. We consider previously well-known models in HIV epidemiology where the parameter for incubation period is used as one of the important components to explain the dynamics of the variables ...
arxiv   +1 more source

Home - About - Disclaimer - Privacy